CTI BioPharma Balance Sheet

Financials in millions HKD. Fiscal year is July - June.

Millions HKD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2016 - 2020
Cash & Equivalents	166.75	145.31	14.75	28.09	36.16	31.17	Upgrade
Short-Term Investments	55.8	36.88	6.42	10.77	8.71	5.69	Upgrade
Cash & Short-Term Investments	222.55	182.19	21.17	38.86	44.87	36.86	Upgrade
Cash Growth	120.10%	760.75%	-45.53%	-13.40%	21.72%	-58.79%	Upgrade
Accounts Receivable	17.57	14.05	7.96	7.08	13.8	5.49	Upgrade
Other Receivables	145.15	138.83	214.15	255.68	149.65	61.17	Upgrade
Receivables	162.72	152.87	260.36	309.34	226.76	66.66	Upgrade
Inventory	18.99	16.45	-	0.05	0.38	0.86	Upgrade
Other Current Assets	-	-	-	7.62	8.6	7.63	Upgrade
Total Current Assets	404.26	351.51	281.53	355.87	280.61	112.01	Upgrade
Property, Plant & Equipment	409.35	243.15	123.15	104.6	119.46	195.28	Upgrade
Long-Term Investments	65.33	43.71	-	-	-	-	Upgrade
Goodwill	-	-	-	-	-	6.52	Upgrade
Other Intangible Assets	263.66	60.06	68.2	72.94	140.98	164.44	Upgrade
Other Long-Term Assets	519.55	560.37	486.69	484.4	535.71	583.26	Upgrade
Total Assets	1,662	1,259	959.57	1,018	1,077	1,062	Upgrade
Accounts Payable	28.95	35.54	14.69	18.98	10.1	16.42	Upgrade
Accrued Expenses	234.75	129.66	69.01	79.24	92.72	150.17	Upgrade
Short-Term Debt	19.76	38.96	302.44	247	213.36	-	Upgrade
Current Portion of Long-Term Debt	20.36	20.83	233.17	74.75	184.44	482.62	Upgrade
Current Portion of Leases	17.96	15.94	9.04	9.36	11.69	7.09	Upgrade
Current Unearned Revenue	41.83	30.48	14.07	14.58	35.33	7.22	Upgrade
Other Current Liabilities	-6.65	-	-	-	-	21.94	Upgrade
Total Current Liabilities	356.97	271.41	642.41	443.91	547.63	685.47	Upgrade
Long-Term Debt	857.13	683.81	20.3	274.4	109.33	4.82	Upgrade
Long-Term Leases	97.1	79.09	78.28	74.41	92.53	22.26	Upgrade
Long-Term Unearned Revenue	-	-	0.38	-	-	12.86	Upgrade
Long-Term Deferred Tax Liabilities	2.39	2.43	3.11	2.28	2.58	20.79	Upgrade
Other Long-Term Liabilities	302.06	16.17	13.65	-	19.89	15.09	Upgrade
Total Liabilities	1,616	1,053	758.14	794.99	771.95	761.29	Upgrade
Common Stock	203.81	203.81	192.89	192.89	192.89	177.1	Upgrade
Additional Paid-In Capital	1,865	1,865	1,783	1,783	1,783	1,564	Upgrade
Retained Earnings	-1,745	-1,627	-1,458	-1,432	-1,393	-1,332	Upgrade
Comprehensive Income & Other	40.12	16.49	1.66	-56.03	-47.96	-81.72	Upgrade
Total Common Equity	364.84	458.27	520.05	488.01	535.3	326.75	Upgrade
Minority Interest	-318.34	-252.37	-318.62	-265.2	-230.49	-26.52	Upgrade
Shareholders' Equity	46.51	205.9	201.44	222.81	304.81	300.23	Upgrade
Total Liabilities & Equity	1,662	1,259	959.57	1,018	1,077	1,062	Upgrade
Total Debt	1,012	838.63	643.22	679.91	611.33	516.8	Upgrade
Net Cash (Debt)	-789.76	-656.44	-622.06	-641.05	-566.46	-479.93	Upgrade
Net Cash Per Share	-0.98	-0.84	-0.81	-0.83	-0.77	-0.68	Upgrade
Filing Date Shares Outstanding	815.26	815.26	771.56	771.56	771.56	708.4	Upgrade
Total Common Shares Outstanding	815.26	815.26	771.56	771.56	771.56	708.4	Upgrade
Working Capital	47.29	80.11	-360.89	-88.04	-267.02	-573.45	Upgrade
Book Value Per Share	0.45	0.56	0.67	0.63	0.69	0.46	Upgrade
Tangible Book Value	101.18	398.21	451.85	415.07	394.32	155.79	Upgrade
Tangible Book Value Per Share	0.12	0.49	0.59	0.54	0.51	0.22	Upgrade
Land	-	216.01	57.32	47.62	44.62	230.23	Upgrade
Machinery	-	71.58	38.55	33.25	32.46	28.09	Upgrade
Construction In Progress	-	28.18	16.37	-	-	-	Upgrade
Leasehold Improvements	-	10.07	8.8	8.81	8.81	9.13	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.